225Actinium-armed antibody targeting CCR8+ regulatory T cells synergizes with immunotherapy to promote tumor rejection in syngeneic colorectal cancer models

靶向 CCR8+ 调节性 T 细胞的 225 锕武装抗体与免疫疗法协同作用，促进同源结直肠癌模型中的肿瘤排斥。